Status:
COMPLETED
A Comparative Study of Adding Ipratropium to Salbutamol for the Treatment of Asthma Attack in Children
Lead Sponsor:
Children's Hospital and Institute of Child Health, Multan
Conditions:
Asthma Exacerbation
Children
Eligibility:
All Genders
2-15 years
Phase:
PHASE4
Brief Summary
The goal of this clinical trial was to determine if adding ipratropium bromide to salbutamol improves asthma treatment in children. The main question this study aimed to answer was: Does combining i...
Detailed Description
Children presenting with asthma exacerbation were assessed for eligibility. Eligible participants had their baseline characteristics recorded including age, gender, history of parental asthma, duratio...
Eligibility Criteria
Inclusion
- Children with acute asthma exacerbation (presenting with wheeze, labored breathing with ronchi audible on auscultation)
- Within 12 hours of symptom onset
Exclusion
- Children with known pulmonary and/or cardiac congenital malformations
- Bronchopulmonary dysplasia
- Cystic fibrosis
- Post infectious bronchiolitis obliterans
- Altered mental status on presentation with imminent respiratory failure (pulmonary asthma score ≥ 10, cases needing PICU care)
Key Trial Info
Start Date :
January 1 2024
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
July 15 2024
Estimated Enrollment :
60 Patients enrolled
Trial Details
Trial ID
NCT06918418
Start Date
January 1 2024
End Date
July 15 2024
Last Update
April 9 2025
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Children's Hospital and Institute of Child Health
Multan, Punjab Province, Pakistan, 60000